IKZF1 is a transcription factor that induces recruitment of the immune infiltrate to tumors and increased sensitivity to PD-1 and CTLA4 inhibitors, including HNSCC. This evidence concerns the gene IKZF1 and head and neck squamous cell carcinoma.